Literature DB >> 8542895

Gastric emptying of two radiolabelled antacids with simultaneous monitoring of gastric pH.

J Monés1, I Carrio, S Sainz, L Berná, P Clavé, M Liszkay, M Roca, F Vilardell.   

Abstract

The aim of this study was to assess the gastric emptying rate of two antacids using an scintigraphic technique and simultaneous monitoring of gastric pH in 16 healthy male volunteers. Ten ml of Talcid (hydrotalcite 1 g) and Maalox (Mg-Al-hydroxide), with a similar neutralization capacity, were labelled with technetium-99m using a pyrophosphate bridge. Labelled antacids were given on separate days (within 2 weeks), 1 h after a standard meal. Intragastric pH was measured for at least 4 h, using ambulatory pH-metry with a dual-crystant antimony catheter. Continuous monitoring was started 1 h prior to the meal (baseline) and lasted 3 h (post-prandial, post-antacid and final periods). The antacid capacity of labelled and unlabelled antacids was similar. The mean percentages of antacids retained in the stomach fitted a linear model. The mean half-emptying time of Talcid was 63.9 +/- 27.9 min, while that of Maalox was 57.3 +/- 23.9 min (P = NS). The recordings of gastric pH (mean values of pH for each period) showed a similar profile for both antacids. The mean pH (Maalox vs Talcid) was 1.69 vs 2.07 in the baseline period, 1.95 vs 1.93 in the post-prandial period, 1.79 vs 1.15 in the post-antacid period (P = NS) and 0.4 vs 0.52 in the final period (P < 0.05 vs prior periods). In conclusion, the gastric emptying of Talcid and Maalox was similar and pH profiles were parallel and remained unchanged for the two antacids within the first hour of intake. A significant decrease in pH was observed 1 h after intake of the antacids, suggesting a possible rebound effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542895     DOI: 10.1007/bf00800593

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  27 in total

1.  Effect of antacid treatment on endogenous prostaglandin synthesis in human antral and duodenal mucosa.

Authors:  G Preclik; E F Stange; K Gerber; G Fetzer; H Horn; A Schneider; H Ditschuneit
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

2.  Healing of chronic gastroduodenal ulcerations by antacids. Role of prostaglandins and epidermal growth factor.

Authors:  S J Konturek; T Brzozowski; D Drozdowicz; A Dembinski; C Nauert
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

3.  A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer.

Authors:  G Fedeli; M Anti; G L Rapaccini; I De Vitis; A Butti; I M Civello
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

4.  Healing of benign gastric ulcer with low-dose antacids and fiber diet.

Authors:  A Rydning; R Weberg; O Lange; A Berstad
Journal:  Gastroenterology       Date:  1986-07       Impact factor: 22.682

5.  Acute effects of antacids on gastric juice components in duodenal ulcer patients.

Authors:  R Weberg; K Berstad; A Berstad
Journal:  Eur J Clin Invest       Date:  1990-10       Impact factor: 4.686

6.  Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer.

Authors:  N Kumar; J C Vij; A Karol; B S Anand
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

7.  Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trial.

Authors:  A F Ippoliti; R A Sturdevant; J I Isenberg; M Binder; R Camacho; R Cano; C Cooney; M M Kline; R L Koretz; J H Meyer; I M Samloff; A D Schwabe; E A Strom; J E Valenzuela; R H Wintroub
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  Treatment of duodenal ulcer with low-dose antacids.

Authors:  G Lux; H Hentschel; H G Rohner; H Brunner; K Schütze; P C Lederer; W Rösch
Journal:  Scand J Gastroenterol       Date:  1986-11       Impact factor: 2.423

9.  Comparison of low-dose antacids, cimetidine, and placebo on 24-hour intragastric acidity in healthy volunteers.

Authors:  R Weberg; A Berstad; M Osnes
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

10.  Efficacy of low-dose antacids in the treatment of peptic ulcers: pharmacological explanation?

Authors:  K F Sewing
Journal:  J Clin Gastroenterol       Date:  1991       Impact factor: 3.062

View more
  2 in total

Review 1.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

2.  Application of absorption modeling to predict bioequivalence outcome of two batches of etoricoxib tablets.

Authors:  Amitava Mitra; Filippos Kesisoglou; Peter Dogterom
Journal:  AAPS PharmSciTech       Date:  2014-09-03       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.